Clinical Trials - The Importance of Diversity in Clinical Trials
Summary
This report provides an analysis of clinical trial racial representation data and evaluates racial demographics across a number of clinical trials sectors to highlight the level of diversity.
Analysis of Racial Representation across Multiple Clinical Trial Sectors
Scope
- The clinical trials data used for these analyses was extracted from GlobalData’s Clinical Trials Database, captured on June 16 and July 19, 2022. The data primarily includes clinical trials initiated from January 1, 2013 to June 16, 2022. Disclosed racial representation data has been analyzed by location, by year, phase, therapy area, sponsor type, top industry sponsors, pivotal study status, single country and multinational trials, decentralized trials, and CRO involvement. Additional analysis on obstacles in the recruitment of diverse subject populations in clinical trials and steps which can be taken to increase diversity have also been included.
- Provides a breakdown of racial representation data across a number of clinical trial sectors.
- Identifies which areas are lacking in clinical trial population diversity.
- Highlights the variation in diversity in the industry and against institutional sponsors.
- Documents the barriers to diversity in clinical trials and outlines steps to improve it.
- Assesses how decentralized and virtual components in clinical trials affect diversity.
- Executive Summary
- Introduction
- Analysis of Diversity in Clinical Trials (2013–2022)
- Key Findings
- Appendix
- List of Figures
- Figure 1: Percentage of clinical trials with disclosed racial representation data by region
- Figure 2: Percentage of clinical trials with disclosed racial representation data in the top 10
- countries for clinical research
- Figure 3: Total representation of studies with racial demographic data
- Figure 4: Racial representation in clinical trials by year
- Figure 5: Proportional race representation in clinical trials by year
- Figure 6: Racial demographic distribution by phase
- Figure 7: Industry sponsors vs. institutional sponsors clinical trials racial representation
- Figure 8: Racial representation in the top five therapy areas
- Figure 9: Proportional racial representation of top company-sponsored trials
- Figure 10: Racial representation in pivotal clinical trials
- Figure 11: Racial representation of single country vs. multinational clinical trials
- Figure 12: Racial representation of decentralized clinical trials vs. traditional trials
- Figure 13: Racial representation of clinical trials with CRO involvement
- Figure 14: Obstacles to clinical trial diversity
- Figure 15: Increasing diversity in clinical trials
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook